Article Versions Notes

Gong K, Xu B, Gong L, Zhong M, Han C, Liu Y, Yin Z, Liang X, Wang Q, Ye G, et al. ITGA2 Mediates the Resistance of Hepatocellular Carcinoma to Lenvatinib by Activating the AKT/FOXO3A Signaling Pathway. Cancers. 2025; 17(17):2846. https://doi.org/10.3390/cancers17172846

Gong, Kai, Bin Xu, Lian Gong, Ming Zhong, Chun Han, Yuechuan Liu, Zeli Yin, Xiangnan Liang, Qiuxiang Wang, Genhua Ye, and et al. 2025. "ITGA2 Mediates the Resistance of Hepatocellular Carcinoma to Lenvatinib by Activating the AKT/FOXO3A Signaling Pathway" Cancers 17, no. 17: 2846. https://doi.org/10.3390/cancers17172846

Gong, K., Xu, B., Gong, L., Zhong, M., Han, C., Liu, Y., Yin, Z., Liang, X., Wang, Q., Ye, G., Sun, B., & Wang, L. (2025). ITGA2 Mediates the Resistance of Hepatocellular Carcinoma to Lenvatinib by Activating the AKT/FOXO3A Signaling Pathway. Cancers, 17(17), 2846. https://doi.org/10.3390/cancers17172846